The effect of the GLP-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes:a randomized double-blind placebo-controlled cross over study
27 August 2016 (11:00 - 16:00)
Organised by:
Abstract
Slides
About the speaker

Odense University Hospital, Odense (Denmark)
47 More presentations in this session
Access the full session
The Event
ESC Congress 2016
27 August 2016
11:00 CET
